Emerging mechanisms progress of colorectal cancer liver metastasis

Front Endocrinol (Lausanne). 2022 Dec 8:13:1081585. doi: 10.3389/fendo.2022.1081585. eCollection 2022.

Abstract

Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present with distant metastasis. The hepatic portal venous system, responsible for collecting most intestinal blood, makes the liver the most common site of CRC metastasis. The formation of liver metastases from colorectal cancer is a long and complex process. It involves the maintenance of primary tumors, vasculature invasion, distant colonization, and metastasis formation. In this review, we serve on how the CRC cells acquire stemness, invade the vascular, and colonize the liver. In addition, we highlight how the resident cells of the liver and immune cells interact with CRC cells. We also discuss the current immunotherapy approaches and challenges we face, and finally, we look forward to finding new therapeutic targets based on novel sequencing technologies.

Keywords: EMT; cancer stem cells; colorectal cancer; liver metastasis; tumor micro environment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colorectal Neoplasms* / pathology
  • Colorectal Neoplasms* / therapy
  • Humans
  • Liver Neoplasms*